An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
2023 · Nature · 166 citations
https://doi.org/10.1038/s41586-023-06797-9
E
Edgar Gonzalez‐Kozlova
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
239
Papers
1.9K
Citations
21
h-index
32
i10-index
Edgar Gonzalez‐Kozlova is an academic researcher from Mount Sinai Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lymphoma Diagnosis and Treatment & Microtubule and mitosis dynamics. The author has an h-index of 21, co-authored 204 publications.
ORCID: 0000-0002-6948-0626Papers by this author
worksGemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
2023 · Nature Medicine · 113 citations
https://doi.org/10.1038/s41591-023-02568-1
The Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application
2024 · Clinical Cancer Research · 11 citations
https://doi.org/10.1158/1078-0432.ccr-24-2469
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals
2022 · Clinical Proteomics · 9 citations
https://doi.org/10.1186/s12014-022-09371-z
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals
2022 · Clinical Proteomics · 9 citations
https://doi.org/10.1186/s12014-022-09371-z
Tumor fitness, immune exhaustion and clinical outcomes: impact of immune checkpoint inhibitors
2020 · Scientific Reports · 8 citations
https://doi.org/10.1038/s41598-020-61992-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat